Missed opportunities in the diagnosis of human immunodeficiency virus infection in the Region of Aragon. Late diagnosis importance

César Gargallo-Bernad1, Francisco Javier Sangrós-González2, Piedad Arazo-Garcés3, Rosa Martínez-Álvarez3, Carmen Malo-Aznar4, Alicia Gargallo-Bernad5, Alba Ballester-Luna6, Luis Eduardo Cabrero-Pascual7, Pablo Gil-Orna8, Víctor José Abadía-Gallego8, Isabel Torres-Peña1, Héctor Ordiz-Suárez9
1Servicio de Urgencias, Hospital de Barbastro, Huesca, Spain
2Centro de Atención Primaria Torrero-La Paz, Sector II Zaragoza, Zaragoza, Spain
3Servicio de Enfermedades Infecciosas, Hospital Universitario Miguel Servet, Zaragoza, Spain
4Dirección General de Salud Pública, Zaragoza, Spain
5Centro de Atención Primaria Casablanca, Sector II Zaragoza, Zaragoza, Spain
6Servicio de Medicina Interna, Hospital Ernest Lluch Martín, Calatayud, Zaragoza, Spain
7Servicio de Medicina Interna, Hospital Arnau de Vilanova, Lérida, Spain
8Servicio de Urgencias, Hospital Universitario Miguel Servet, Zaragoza, Spain
9Servicio de Urgencias, Fundación Hospital de Calahorra, Logroño, Spain

Tài liệu tham khảo

Antinori, 2011, Late presentation of HIV infection: a consensus definition, HIV Med, 12, 61, 10.1111/j.1468-1293.2010.00857.x Lucas, 2008, National review of deaths among HIV-infected adults, Clin Med, 8, 250, 10.7861/clinmedicine.8-3-250 Chadbron, 2006, The late diagnosis and consecuent short-term mortality of HIV-infected heterosexuals (England and Wales 2000–2004), AIDS, 20, 2371, 10.1097/QAD.0b013e32801138f7 Sobrino-Vegas, 2009, Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality, Curr HIV Res, 7, 224, 10.2174/157016209787581535 2011 Campsmith, 2010, Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006, J Acquir Immune Defic Syndr, 53, 619, 10.1097/QAI.0b013e3181bf1c45 2010, Prevalence and awareness of HIV infection among men who have sex with men — 21 cities, United States, 2008, Morb Mortal Wkly Rep, 59, 1201 Mounier-Jack, 2008, HIV testing strategies across European countries, HIV Med, 9, 13, 10.1111/j.1468-1293.2008.00585.x Enfermedades indicadoras de infección por VIH: Guía para la realización de la prueba del VIH a adultos en entornos sanitarios. HIV en Europe initiative, HIV indicator conditions: guidance for implementing HIV testing in adults in health care settings [accessed 16 Feb 2017]. Available in: http://hiveurope.eu. Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional sobre Sida, Guía de recomendaciones para el diagnóstico precoz de VIH en el ámbito sanitario; 2014. Instituto Aragonés de Estadística con Padrón Municipal de Habitantes. Comunidad Autónoma de Aragón [2011, 2012, 2013, 2014, 2015] [accessed 23 Mar 2017]. Available in: http://servicios3.aragon.es/iaeaxi/tabla.do?path=/02/01/01/01/&file=0201010101.px&type=pcaxis&L=0 Área de Vigilancia de VIH y Comportamientos de Riesgo. Vigilancia Epidemiológica del VIH y sida en España: Sistema de Información sobre Nuevos Diagnósticos de VIH y Registro Nacional de Casos de Sida. Plan Nacional sobre el Sida – S.G. de Promoción de la Salud y Epidemiología/Centro Nacional de Epidemiología – ISCIII. Madrid; 2016. UNAIDS report on the global AIDS epidemic. Geneva, 2016 [accessed 18 Apr 2017]. Available in: https://www.unaids.org 2016 Sobrino-Vegas, 2011, The Cohort of the Spanish HIV Research Network (CoRIS) and its associated biobank organizational issues, main findings and losses to follow-up, Enfer Infecc Microbiol Clin, 29, 645, 10.1016/j.eimc.2011.06.002 Mahendran, 2015, Testing initiatives increase rates of HIV diagnosis in primary care and community settings: an observational single-centre cohort study, PLoS One, 10, e0124394, 10.1371/journal.pone.0124394 2010, The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals, AIDS, 24, 123, 10.1097/QAD.0b013e3283324283 Poorolajal, 2016, Survival rate of AIDS disease and mortality in HIV-infected patients: a meta-analysis, Public Health, 139, 3, 10.1016/j.puhe.2016.05.004 Yang, 2008, Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984–2005, HIV Med, 9, 535, 10.1111/j.1468-1293.2008.00600.x Egger, 2002, Prognosis of HIV-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies, Lancet, 360, 119, 10.1016/S0140-6736(02)09411-4 Walensky, 2006, The survival benefits of AIDS treatment in the United States, J Infect Dis, 194, 11, 10.1086/505147 Levy, 2016, Missed opportunities for earlier diagnosis of HIV in patients who presented with advanced HIV disease: a retrospective cohort study, BMJ Open, 6, e012721, 10.1136/bmjopen-2016-012721 Wohlgemut, 2012, Trends in missed presentations and late HIV diagnosis in a UK teaching hospital: a retrospective comparative cohort study, BMC Infect Dis, 12, 72, 10.1186/1471-2334-12-72 Rivero Marcotegui, 2014, Diagnóstico tardío de la infección por el virus de la inmunodeficiencia humana: oportunidades diagnósticas perdidas, An Sist Sanit Navar, 37, 329, 10.4321/S1137-66272014000300003 Gullón, 2016, Factors associated with late diagnosis of HIV infection and missed opportunities for earlier testing, AIDS Care, 28, 1296, 10.1080/09540121.2016.1178700 Joore, 2015, HIV indicator condition-guided testing to reduce the number of undiagnosed patients and prevent late presentation in a high-prevalence area: a case–control study in primary care, Sex Transm Infect, 91, 467, 10.1136/sextrans-2015-052073 Joore, 2016, The need to scale up HIV indicator condition-guided testing for early case-finding: a case–control study in primary care, BMC Fam Pract, 17, 161, 10.1186/s12875-016-0556-2 Downing, 2017, Missed opportunities for HIV diagnosis, J Int Assoc Provid AIDS Care, 16, 14, 10.1177/2325957416661423 Ellis, 2012, HIV diagnoses and missed opportunities. Results of the British HIV Association (BHIVA) National Audit 2010, Clin Med, 12, 430, 10.7861/clinmedicine.12-5-430 Sanders, 2005, Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy, N Engl J Med, 352, 570, 10.1056/NEJMsa042657